Oncology product range extended with the launch of paclitaxel and vinorelbine
Oncology product range extended with the launch of paclitaxel and vinorelbine
At Wockhardt UK, we are continuing to build and strengthen our oncology product portfolio. Two injectable cytotoxic products have been launched: For more information about these products, please see Related Documents, or alternatively click here to be directed to our Oncology Key Therapy Area page. You can also use the Product Search function to locate the appropriate product catalogue pages.For more information about our Hospital Medicines division, please click here. Wockhardt UK is looking forward to introducing further products throughout the remainder of 2006 so watch the News section for the most up to date launch information. 
|
